Bioactive Molecules via Morita–Baylis–Hillman Chemistry
Abstract Morita–Baylis–Hillman (MBH) chemistry was applied to the synthesis of a variety of new chemical entities and their bioactivity was evaluated. Various substances synthesized via MBH chemistry have: antimalarial, anti-inflammatory, antidiabetic, antimicrobial, antitubercular, and anticancer activity and also act as phosphodiesterase inhibitors. There are a few instances animal model and biology studies explored. Several hits and lead molecules are identified and their IC50 values listed. The simplicity of Morita–Baylis–Hillman chemistry provides a realistic, impactful option for the pharma industry. 1 Introduction 2 Antimalarial Activity 3 Anti-inflammatory Activity of MBH Adducts Coupled to Heterocycles 4 Antidiabetic Activity of Epalrestat Analogues Derived from MBH Adducts 5 Antimicrobial Activity 6 Antitubercular Activity of N-Cinnamyl-isatins 7 Inhibitors of Phosphodiesterase-3 (PDE3); Cardiotonic Agents 8 Anticancer Activity 9 Asymmetric Morita–Baylis–Hillman Reactions 10 Conclusion
Authors
- Nitish Kumar (ORCID: https://orcid.org/0000-0003-1257-0054)
- vaidya Jayathirtharao
Institutions
- Vignan's Foundation for Science, Technology & Research (IN)
- Laboratoire de Synthèse Organique (FR)
- Indian Institute of Chemical Technology (IN)
Publication Details
- Journal
- Synlett
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1055/a-2535-1306
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00